There are a few people on these posts throwing numbers of competing cannepil products around. First it is a few and now its four hundred? Where is the proof and are all the competing products able to be administered under the authorised prescriber scheme. You seem to have a good hold on whats going on in this space sparkz. Would any administration of a competing product on a patient need firstly to be TGA approved?
Ann: Completion of MGC Derma Sale to CannaGlobal, page-43
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.040(9.30%) |
Mkt cap ! $20.90M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 36.0¢ | $15.26K | 39.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 15.55pm 17/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |